119th CONGRESS
1st Session
H. R. 5160


To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.


IN THE HOUSE OF REPRESENTATIVES

September 4, 2025

Mr. Smith of New Jersey (for himself, Ms. Matsui, Mr. Bilirakis, Ms. Pingree, Ms. Tenney, and Mr. Mfume) introduced the following bill; which was referred to the Committee on Energy and Commerce


A BILL

To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Stem Cell Therapeutic and Research Reauthorization Act of 2025”.

SEC. 2. Reauthorization of the C.W. Bill Young Cell Transplantation Program.

Section 379B of the Public Health Service Act (42 U.S.C. 274m) is amended—

(1) by striking “appropriated $31,009,000” and inserting the following: “appropriated—

“(1) $31,009,000”;

(2) in paragraph (1), as so inserted, by striking the period at the end and inserting “; and”; and

(3) by adding at the end the following:

“(2) $33,009,000 for each of fiscal years 2027 through 2031.”.

SEC. 3. Cord blood inventory.

Section 2(g) of the Stem Cell Therapeutic and Research Act of 2005 (42 U.S.C. 274k note) is amended by striking “2026” and inserting “2031”.